Scandinavian ChemoTech AB Class B (8V6) Financial Statements
Scandinavian ChemoTech AB Class B Financial Overview
Scandinavian ChemoTech AB Class B's market cap is currently $5.36M. The company's EPS TTM is $-0.25; its P/E ratio is -14.45; Scandinavian ChemoTech AB Class B has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 12.29M | $ 6.57M | $ 2.82M | $ 473.00K | $ 49.00K |
| Gross Profit | $ -4.50M | $ 4.78M | $ 1.66M | $ -55.00K | $ 323.00K |
| Operating Income | $ -6.30M | $ -12.80M | $ -20.24M | $ -20.91M | $ -17.08M |
| EBITDA | $ -4.33M | $ -12.38M | $ -19.58M | $ -20.81M | $ -17.03M |
| Net Income | $ -8.06M | $ -13.72M | $ -21.09M | $ -22.75M | $ -17.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.67M | $ 949.00K | $ 923.00K | $ 5.85M | $ 8.68M |
| Total Assets | $ 13.20M | $ 13.38M | $ 14.87M | $ 21.70M | $ 25.81M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 53.00K |
| Net Debt | $ -3.67M | $ -949.00K | $ -923.00K | $ -5.85M | $ -8.63M |
| Total Liabilities | $ 10.01M | $ 7.40M | $ 3.84M | $ 7.71M | $ 1.89M |
| Stockholders' Equity | $ 3.19M | $ 5.98M | $ 11.03M | $ 13.99M | $ 23.92M |
| Cash Flow | |||||
| Free Cash Flow | $ -4.18M | $ -13.19M | $ -18.91M | $ -19.96M | $ -22.36M |
| Operating Cash Flow | $ -3.75M | $ -13.14M | $ -18.23M | $ -19.63M | $ -19.18M |
| Investing Cash Flow | $ -426.00K | $ -2.00K | $ -468.00K | $ -603.00K | $ -3.33M |
| Financing Cash Flow | $ 6.89M | $ 13.17M | $ 13.77M | $ 17.26M | $ 29.71M |
Currency in SEK